Lung function testing in COPD patients starting triple therapy
Part of Lungs & breathing clinical trials.
This study uses a breathing test called oscillometry to check how your lungs are working. It is for people with moderate to severe COPD who are about to start triple inhaler therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have COPD that is moderate or severe but stable
- You have been using a dual bronchodilator inhaler (LABA/LAMA) for at least 4 months
- You have had at least one COPD flare-up (exacerbation)
- Your blood eosinophil count was over 100 cells/mL in a recent test
- You have not used an inhaled corticosteroid (ICS) in the last 4 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a new breathing device to standard tests for diagnosing asthma and COPD. If you have been referred for breathing tests because your doctor suspects asthma or COPD, you may be able to join.
This study uses a simple breathing test called oscillometry along with machine learning to better understand lung conditions like COPD, asthma, and interstitial lung disease. It may help find new ways to diagnose and track these diseases.
This study compares simple breathing tests (oscillometry and FeNO) used by your primary care doctor against a specialist's diagnosis to see if they can accurately tell if you have asthma or COPD. If you have symptoms like wheezing, cough, or shortness of breath but haven't been diagnosed yet, this trial may help improve how these conditions are found.
This study checks how exhaled breath changes over 6-month visits in people with COPD, to see if it can help track lung health over time. It may help find new ways to monitor your condition without invasive tests.
This study looks at how often heart problems or stroke happen in people with COPD after they start a specific “triple therapy” inhaler. It may help doctors understand whether these inhalers change cardiovascular (heart) or cerebrovascular (stroke) risk.
This study tests whether a new approach can help relieve severe shortness of breath in people with COPD who are already on standard inhaler therapy. It may help you breathe easier and improve your daily life.
Hear when a new COPD (Chronic Obstructive Pulmonary Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.